PatientsVille.com Logo

Lower and Mucinex

PatientsVille

Lower Symptoms and Causes

What is cholesterol?

Your body needs some cholesterol to work properly. But if you have too much in your blood, it can stick to the walls of your arteries and narrow or even block them. This puts you at risk for coronary artery disease and other heart diseases.

There are two main types of cholesterol. LDL is the "bad" cholesterol. A high LDL level leads to a buildup of cholesterol in your arteries. HDL is the "good" cholesterol. It carries cholesterol from other parts of your body back to your liver. Then your liver removes the cholesterol from your body.

There are steps that you can take to Lower your LDL (bad) cholesterol and raise your HDL (good) cholesterol. By keeping your cholesterol levels in range, you can Lower your risk of heart diseases.

What are the treatments for high cholesterol?

The main treatments for high cholesterol are lifestyle changes and medicines.

Lifestyle changes to Lower cholesterol

Heart-healthy lifestyle changes that can help you Lower or control your cholesterol include

  • Heart-healthy eating. A heart-healthy eating plan limits the amount of saturated and trans fats that you eat. It recommends that you eat and drink only enough calories to stay at a healthy weight and avoid weight gain. It encourages you to choose a variety of nutritious foods, including fruits, vegetables, whole grains, and lean meats. Examples of eating plans that can Lower your cholesterol include the Therapeutic Lifestyle Changes diet and the DASH eating plan.
  • Weight Management. If you are overweight, losing weight can help Lower your LDL (bad) cholesterol. This is especially important for people with metabolic syndrome. Metabolic syndrome is a group of risk factors that includes high triglyceride levels, low HDL (good) cholesterol levels, and being overweight with a large waist measurement (more than 40 inches for men and more than 35 inches for women).
  • Physical Activity. Everyone should get regular physical activity (30 minutes on most, if not all, days).
  • Managing stress. Research has shown that chronic stress can sometimes raise your LDL cholesterol and Lower your HDL cholesterol.
  • Quitting smoking.Quitting smoking can raise your HDL cholesterol. Since HDL helps to remove LDL cholesterol from your arteries, having more HDL can help to Lower your LDL cholesterol.
Medicines to Lower cholesterol

For some people, making lifestyle changes alone does not their Lower cholesterol enough. They may also need to take medicines. There are several types of cholesterol-Lowering drugs available. They work in different ways and can have different side effects. Talk to your health care provider about which medicine is right for you.

Even if you take medicines to Lower your cholesterol, you still need to continue with lifestyle changes.

Lipoprotein apheresis to Lower cholesterol

Familial hypercholesterolemia (FH) is an inherited form of high cholesterol. Some people who have FH may get a treatment called lipoprotein apheresis. This treatment uses a filtering machine to remove LDL cholesterol from the blood. Then the machine returns the rest of the blood back to the person.

Supplements to Lower cholesterol

Some companies sell supplements that they say can Lower cholesterol. Researchers have studied many of these supplements, including red yeast rice, flaxseed, and garlic. At this time, there isn't conclusive evidence that any of them are effective in Lowering cholesterol levels. Also, supplements may cause side effects and interactions with medicines. Always check with your health care provider before you take any supplements.

Check out the latest treatments for lower

lower treatment research studies

Mucinex clinical trials, surveys and public health registries


Find Drug Side Effect reports



Mucinex Side Effects

Dizziness (348)
Blood Pressure Increased (229)
Headache (184)
Nausea (173)
Epistaxis (169)
Feeling Abnormal (159)
Heart Rate Increased (130)
Diarrhoea (124)
Hallucination (121)
Insomnia (119)
Dyspnoea (110)
Anxiety (109)
Vomiting (87)
Hypertension (73)
Confusional State (70)
Loss Of Consciousness (63)
Haemoptysis (62)
Tremor (55)
Asthenia (53)
Somnolence (46)
Palpitations (43)
Nervousness (41)
Off Label Use (38)
Hyperhidrosis (35)
Disorientation (35)
Urticaria (34)
Fatigue (34)
Abdominal Pain Upper (32)
Accidental Overdose (30)
Overdose (30)
Chest Pain (29)
Convulsion (28)
Cough (28)
Malaise (25)
Feeling Jittery (24)
Syncope (24)
Hypoaesthesia (24)
Lip Swelling (23)
Lethargy (23)
Psychomotor Hyperactivity (22)
Hypersensitivity (22)
Pharyngeal Oedema (22)
Faeces Discoloured (22)
Agitation (22)
Rash (21)
Chest Discomfort (21)
Unevaluable Event (21)
Vision Blurred (21)
Mucosal Haemorrhage (20)
Dysphagia (20)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

I took Mucinex DM 1200mg once at 10:30 pm and again at 10:30 am. By noon I wasnt functional at all, I had severe loss of focus, my eyes were dilated, and I was really slow, on top of the usual side effects of being jittery and nauseous. Since

I am having a horrible experience with this drug (Mucinex DM). Certainly it 'loosens mucous' in my bronchial tubes, but it then seems to pump fluids into my lungs at an alarming rate, and I must force agressive

I took mucinex dm maximum strength last night around 2:30 am because i couldn't stop coughing and it the cough wasn't letting me go to sleep..someone from the pharmacy at walgreens recommended it..anyways around 6:30 am i started

<span style='color: #808080;'>I would like to share my experience with anyone that can read this.I have Fibromyalgia.I use guaifenesin to expell all the calcium phosphates from my body.I have been taking it over 6 years.Mucinex pretty much has

I started taking MuccinexD yesterday. I didnt know if it was just me being sick or if it was the medicine until I called the on call doctor. I got bad diarreah, and everytime I got up I felt dizzy and almost outside myself. It

Liquid Poop... took just ONE pill at 1:00pm and on the toilet 4 times already and it has only been 2 hours since i took it... i sure hope this goes away. Well i know the bottle is cause I'm not taking it again. It's fu

<strong>I have COPD/emphysema... and a few months ago I used Mucinex to try and help clear me up but, I didn't know at that time..it only made it worse. I was taken to ER. Just last week I started having trouble breathing and coughin up the gar

1st time taking Musinex DM. On a red eye flight. Worst experience ever. About 2 hrs. of taking this Musinex DM I woke up with tingling all over my body, sweating profusely, nausa, and can't think clean.. It lasted around 9 hours. I prayed for this da

38 yr old female within a few hours after taking mucinex d i began feeling frusterated, impatient,aggitated, short tempered, and felt overall not myself. i had to put my 1 and 3 year olds to bed early to avoid them dealing with m

42 y.o. female, no medical hx. of urinary incontinence until the use of Mucinex D 1200mg po bid. Resolved after med. being discontinued.

<b><span style='font-weight: normal;'><b>After 6 weeks of oral lamisil I experienced</b>eczema, muscle weakness, asthma, bloody bowels, lower abdominal pain, dizziness, extreme f

63 yo man received Zostavax injection in the left upper arm 12/13/11. Developed painful blister on the right shoulder and pain at the right lower ribs 12/10/11.

&lt;!--StartFragment--&gt; I am 58 female and about to start Etoricoxib 60mg. My doctor prescribed this mediation for my lower back and left thigh pain. I am in US and my doctor is in India. I am supposed to take 1 pil

I am 12 weeks pregnant and last night i felt a pain on my lower right stomach trying to change the position i was sleeping and it was uncormfotable and very painful that i even screamed a little and after 2 minutes or so it went away and fa

<strong></strong><span style='text-decoration: underline;'>the appendix is on the lower rightpart of your torso

When I press down on my stomach, in the lower right side in the pelvic region it hurts. Right by my hip bone. This has been going on for about a week. Could this be really bad? Im scared that I could be pregnant. but i dont think

Since starting champix i have experienced severral side effects including: -increased urination -lower back pain -extreme fatigue -mood swings -decrease in sex drive

' i am in so much pain in my lower stomas I can hardly walk.' Feel the same thing,like a pms

11 month old developed cough and petechiae 1 week after Hib vaccination (isolated to lower abdomen). Thought this was viral until he recieved polio and HepB 1 month later (1 year) and developed petechiae again this time all over abdomen and back, and

64 years old. Good health, high BP extreme tension stress from work. Started lisinopril didn't lower BP, changed to Bystolic 10mg, lowered BP quickly, Constantly tired feeling, vey dizzy mostly in the morning constant coughing up mucus, lungs clear

Lower Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Comparison Between Oxomemazine, Guaifenesin and Potassium Iodate Versus Guaifenesin Monotherapy in Acute Cough Treatment
Condition: Cough
Interventions: Drug: Syrup of oxomemazine, guaifenesin and potassium iodate;   Drug: Syrup of guaifenesin
Outcome Measures: Reduction/improvement of cough symptoms;   Tolerance
2 Recruiting Single Dose Trial of Extended Release Combination Tablet Codeine and Guaifenesin
Condition: Cough
Interventions: Drug: Extended Release Codeine Phosaphate/Guaifenesin Tablet 30 mg/600 mg;   Drug: IR Codeine Phosphate/Guaifenesin 20 mg/400 mg
Outcome Measures: Serum Levels of Codeine and Guaifenesin;   Safety and Tolerability
3 Not yet recruiting Triac Trial in MCT8 Patients
Condition: Allan-Herndon-Dudley Syndrome
Intervention: Drug: Triac
Outcome Measures: serum thyroid function tests;   general clinical examination;   tissue-specific markers of thyroid state;   Motor function, using the Gross Motor Function Measure;   Cognitive function using the Bayley Scales of Infant Development III;   Adaptive behavior by the Vineland adaptive behavior scale
4 Recruiting The Effect of Oral Guaifenesin on Pediatric Chronic Rhinitis: A Pilot Study
Condition: Chronic Rhinitis
Interventions: Drug: Placebo;   Drug: Guaifenesin
Outcome Measures: Subjective nasal scoring;   Nasal Volume;   Nasal Secretion Collection
5 Recruiting Effects of Su-Huang Antitussive Capsule on Cough Variant Asthma
Condition: Asthma
Interventions: Drug: Su-Huang antitussive capsule;   Drug: Sugar pill
Outcome Measures: Day-time and night-time cough symptom total-score changes from baseline to visit 3;   Cough reflex sensitivity changes in 2 groups at baseline and visit 3. Cell differential changes in hypertonic saline induced sputum in 2 groups at baseline and visit3.
6 Unknown  Comparison Between Dexchlorpheniramine and Dexchlorpheniramine/Pseudoephedrine/Guaifenesin in Respiratory Infections
Condition: Viral Infections of the Upper Respiratory Tract
Interventions: Drug: Dexchlorpheniramine, pseudoephedrine, guaifenesin;   Drug: Dexchlorpheniramine
Outcome Measures: Symptoms frequency and intensity evaluated with a 5 point visual analogic scale (VAS);   Subjective evaluation of efficacy and tolerability graded as excellent, good, fair ou poor.
7 Unknown  Effectiveness and Safety of the of Guaifenesin, Doxylamine Succinate and Hydrochloride Etafedrine Syrup in Improvement of Symptoms Resulting From Acute Respiratory Infections.
Condition: Upper Airway Infections
Interventions: Drug: EMS Expectorant;   Other: Placebo
Outcome Measures: - Decrease in nasal secretion - Decrease in sneezing - Reduction of edema of the nasal mucosa - Decreased frequency of cough - Decrease the frequency of dyspnea - Reduction of nasal obstruction;   Will be assessed for safety by the incidence of adverse reactions
8 Unknown  Comparative Efficacy of the Suppository Versus Guaiacol Suppository Versus Guaifenesin Syrup in Pediatric Patients With Cough Due the Infectious Origin
Condition: Cough
Interventions: Drug: Guaiacol, eucalyptol, menthol and camphor suppository;   Drug: guaiacol suppository;   Drug: Guaifenesin syrup
Outcome Measures: Improvement of cough of infectious origin.;   Analysis of parameters for the improvement of infectious cough.
9 Recruiting Antitussive Effect of a Naturally Flavored Syrup Containing Diphenhydramine, Compared With Dextromethorphan and Placebo
Condition: Cough Reflex Sensitivity
Interventions: Drug: Phenylephrine;   Drug: Diphenhydramine;   Drug: Dextromethorphan
Outcome Measure: change in cough reflex sensitivity to capsaicin
10 Not yet recruiting Effect of Cyclodextrin on Sensory Nerve Activity: A Novel Anti-tussive Therapy
Condition: Cough
Intervention: Drug: cyclodextrin
Outcome Measure: Capsaicin Cough Challenge
11 Unknown  Postoperative Analgesia in Children After Propofol Anesthesia
Condition: Postoperative Pain
Intervention: Drug: Propofol
Outcome Measures: postoperative pain;   recovery time;   adverse effects
12 Recruiting A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Aclidinium bromide;   Drug: Placebo
Outcome Measures: Change from baseline in normalised forced expiratory volume in one second (FEV1);   Adverse events
13 Recruiting Study of NMDA Antagonists and Neuropathic Pain
Condition: Neuropathic Pain
Interventions: Drug: Dextromethorphan (drug used like antitussive);   Drug: Memantine (drug used in Alzheimer's disease);   Drug: Placebo (lactose)
Outcome Measures: Measure of pain by numerical scale;   Patient Global Impression if Change (PGIC);   Leed's slip questionnaire;   Questionnaire of quality of life SF 36;   DN4 scale;   Neuropathic Pain Symptoms Inventory (NPSI);   Saint-Antoine questionnaire (QDSA);   HAD scale;   Questionnaire of identification of pain (QCD);   Evaluation of cognitive impact (Cantab, Cambridge)
14 Recruiting In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study
Conditions: Pancreatic Cancer;   Esophageal Cancer;   Rectal Cancer
Intervention: Drug: [F-18]HX4
Outcome Measures: Reproducibility of SUV measured with 18F-HX4 PET;   Optimal time frame between administration of 18F-HX4 and PET scan
15 Recruiting A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: MSC;   Drug: "celecoxib", "Celebrex®"
Outcome Measures: the proportion of patients which disease activity reaches ASAS(assessment in ankylosing Spondylitis)20 remission criteria;   BASDAI score comparing to baseline;   BASFI score comparing to baseline
16 Recruiting A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Erlotinib;   Dietary Supplement: Silybin-phytosome
Outcome Measures: Tumour response rate;   Safety assessment
17 Recruiting Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: placebo;   Drug: exenatide
Outcome Measures: The primary objective of this study is to test the hypothesis that glycemic control with exenatide is superior to that of placebo after 28 weeks of treatment in adolescent patients;   Exenatide 5 µg BID vs. Exenatide 10 µg BID vs. placebo to compare: • the proportion of patients achieving an HbA1c at endpoint of ≤7%, <7%, ≤6.5% and <6.5% • body weight • fasting serum glucose • self-monitored blood glucose
18 Unknown  Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections
Condition: Helicobacter Pylori Infection
Interventions: Drug: RA5-RACM7;   Drug: RA3-RACM7;   Drug: RA7-RACM7
Outcome Measure: Eradication rate
19 Recruiting Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: pantoprazole, amoxicillin, clarithromycin, metronidazole;   Drug: pantoprazole, amoxicillin, clarithromycin, metronidzole
Outcome Measure: Comparison of the eradications rates of sequential therapy versus concomitant therapy of treatment of Helicobacter pylori infection in Korea.
20 Recruiting The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome
Condition: Pancreatic Cancer
Interventions: Drug: Gadobutrol;   Drug: [F-18]HX4;   Drug: Gemcitabine;   Radiation: Radiotherapy;   Procedure: Pancreaticoduodenectomy
Outcome Measures: Predictive value of pretreatment DWI, DCE-MRI, T2*, and 18F-HX4-PET/CT on overall survival in patients with pancreatic cancer treated with surgery and adjuvant chemotherapy or with neoadjuvant radiochemotherapy, surgery and adjuvant chemotherapy.;   Predictive value of pretreatment DWI, DCE-MRI, T2*, and 18F-HX4-PET/CT on recurrence free survival in patients with pancreatic cancer treated with surgery and adjuvant chemotherapy or with neoadjuvant radiochemotherapy, surgery and adjuvant chemotherapy.;   Predictive value of pretreatment DWI, DCE-MRI, T2*, and 18F-HX4-PET/CT on pathological response in patients with pancreatic cancer treated with neoadjuvant radiochemotherapy;   Predictive value of changes in DWI, DCE-MRI, T2*, and 18F-HX4-PET/CT parameters after radiochemotherapy on pathological response in patients with pancreatic cancer treated with neoadjuvant radiochemotherapy;   Predictive value of changes in DWI, DCE-MRI, T2*, and 18F-HX4-PET/CT parameters after radiochemotherapy on recurrence-free survival in patients with pancreatic cancer treated with neoadjuvant radiochemotherapy, surgery and adjuvant chemotherapy;   Immunohistochemically determined parameters of the tumor microenvironment assessed after resection of the pancreatic tumor to predict overall and recurrence-free survival;   Immunohistochemically determined parameters of the tumor microenvironment assessed in a pretreatment tumor biopsy to predict overall and recurrence-free survival